Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical

@article{Hesselink2013EvolutionIP,
  title={Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical},
  author={J. M. Hesselink},
  journal={Journal of Pain Research},
  year={2013},
  volume={6},
  pages={625 - 634}
}
  • J. M. Hesselink
  • Published 2013
  • Biology, Medicine
  • Journal of Pain Research
  • The history of development of new concepts in pharmacology is a highly interesting topic. This review discusses scientific insights related to palmitoylethanolamide (PEA) and its progression over a period of six decades, especially in light of the work of the science sociologists, Ludwig Fleck and Thomas Kuhn. The discovery of the cannabis receptors and the nuclear peroxisome proliferator-activated receptors was the beginning of a completely new understanding of many important homeostatic… CONTINUE READING
    27 Citations
    Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases
    • 13
    N-Palmitoylethanolamide Exerts Antidepressant-Like Effects in Rats: Involvement of PPARα Pathway in the Hippocampus
    • 4
    • PDF
    Autacoids: A New Fundament for Pain Medicine of the 21th Century
    • PDF
    Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome
    • 40

    References

    SHOWING 1-10 OF 71 REFERENCES
    New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoyletha- nolamide
    • 51
    • PDF
    SLOW ENCEPHALOPATHIES, INFLAMMATORY RESPONSES, AND ARACHIS OIL
    • 21
    Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury
    • 88
    • PDF